尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Craig Kevin James. Insider active across 2 companies, notably ATAI Life Sciences N.V.. Cumulatively, 12 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €502k. History available since 21 March 2025. The latest transaction was filed on 20 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Craig Kevin James is a declarant linked to AtaiBeckley Inc. and ATAI Life Sciences N.V., where his listed role is Chief Medical Officer. He has 11 filings in total, and across the 11 sampled filings between 2025-03-19 and 2026-06-29, the reported sell amount is EUR 501664 and the most frequent transaction nature is Option exercise.